Schedule 13G ownership disclosure

SYROS PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 87184Q107

Event date: 2022-02-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-035576
Form type
SC 13G
Filer
Artal International S.C.A.
CIK
CIK 1218180
Filed
Feb 11, 2022
Reporting period
Feb 02, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub